Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia

Rehmannioside A is derived from Rehmannia glutinosa Libosch, which is widely used as an important ingredient in diverse traditional Chinese medicines to treat diseases caused by “kidney deficiency” such as cerebral arteriosclerosis, aging-related stroke and dementia in China. Recent studies have pro...

Full description

Saved in:
Bibliographic Details
Published inJournal of ethnopharmacology Vol. 289; no. NA; p. 115021
Main Authors Fu, Chen, Wu, Yifan, Liu, Shaojiao, Luo, Chaoqin, Lu, Yuqiao, Liu, Menghan, Wang, Lingfeng, Zhang, Yunling, Liu, Xuemei
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 10.05.2022
Subjects
Online AccessGet full text

Cover

Loading…